MondayMar 19, 2018 11:54 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Details Cannabis Exportation Agreement for Sol-gel Research

Permits obtained for importation of cannabis into Australia PreveCeutical conducting research at University of Queensland for cannabinoid-based Sol-gel products Cannabis-based Sol-gel products targeted at relieving symptoms such as pain, inflammation, seizures and neurological disorders PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), a health sciences company aiming to become a preventive health sciences leader, has announced the grant of three permits from the Australian government’s Department of Health allowing for the importation of cannabis into Australia for purposes of research. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (PACE) at the University of Queensland,…

Continue Reading

FridayMar 16, 2018 2:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Generate up to 80% of Revenues from Technology Licensing

CEO Chris Bunka says in audio interview that human study of company’s proprietary TurboCBD technology will start in April outside of North America Hopes to add 6-12 more IP technology licensing contracts within year Cutting-edge research designed to attract the attention of tobacco and cannabis industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent audio interview that, although consumer products will always be important to LXRP, he estimates that up to 80 percent of its revenues could be generated through the licensing of its proprietary technology to other companies (http://cnw.fm/yT2HS). LXRP is a British…

Continue Reading

FridayMar 16, 2018 12:53 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Readies Niche Products for Legal Cannabis Industry

Spending on legal cannabis worldwide expected to hit $57 billion by 2027 Canadian government preparing to legalize cannabis-infused edibles and beverages by mid-2019 Investments into cannabis-related companies topped $1.2 billion over first five weeks of 2018 Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis…

Continue Reading

ThursdayMar 15, 2018 4:10 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Continues to Advance its Agenda

Owns worldwide rights for patented formulations and drug delivery technologies Develops and commercializes therapeutic pharmaceuticals and nutraceuticals Strategic agenda to become one of world’s only vertically integrated cannabis biotechs With worldwide rights for unique drug delivery platforms in place, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rapidly building a disruptive, vertically integrated biotechnology company. Advancing this agenda, the company recently announced that it has retained Cannabis Compliance Inc. to submit an application to Health Canada for a dealer’s license on behalf of Pivot’s acquisition target, Agro-Biotech Inc. (http://cnw.fm/0K5Xn). In February, Pivot announced that its entry into a…

Continue Reading

ThursdayMar 15, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

Research will be conducted at PACE, a leading pharmaceutical research center in Australia PreveCeutical’s unique technology promises to be the first FDA-approved, CBD-based nose-to-brain delivery system using a Sol-gel platform Groundbreaking technology outstrips the benefits of any other delivery mechanism On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis…

Continue Reading

WednesdayMar 14, 2018 12:12 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Completes $1.5 Million Private Placement

Proceeds to be used for development of new cultivation and processing project in New Brunswick A boost to operating capital Canada plans to legalize the extraction of cannabinoids from hemp in mid-2018 Market for hemp CBD products is predicted to grow to $450 million by 2020 Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets, announced on March 7, 2018, that it had closed a non-brokered private placement, consisting of 12.5 million units at a price of $0.12 per unit, to raise…

Continue Reading

TuesdayMar 13, 2018 12:24 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Finding Ever-Growing Ways to Administer Cannabis Benefits

Pivot Pharmaceuticals developing disruptive formulations for cannabis-infused markets Company’s goal is to strengthen dosage predictability and improve product stability Recent acquisitions and planned acquisitions give Pivot vertical position in multi-billion-dollar industries Despite recent setbacks to efforts seeking broader marijuana legalization in North America (http://cnw.fm/zM2Mc), the tide of social preferences for cannabis availability, even in recreational applications, continues to advance (http://cnw.fm/tT62e). Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is helping to advance efforts to legitimize the drug’s use, both in medicinal and recreational settings, by pursuing ever-increasing methods for consuming cannabis’s derivatives in quantities with predictable outcomes. “Pivot’s goal…

Continue Reading

MondayMar 12, 2018 4:13 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Linker Tech Mimics Body’s Production of Pain Relieving Peptides

Developing pain relievers that mimic body’s natural pain relief peptides Other programs include development of treatments for diabetes, synthetization of blue scorpion venom and study of a novel cannabinoid delivery platform Revenues from international licensing strategy The discovery of endomorphins in 1997 was a remarkable reminder of the human body’s wondrous nature. Endomorphins are naturally produced morphine-like substances with an affinity for the µ-opioid receptors in the brain, which fortunately happen to be the best places to alleviate pain. With a potency that far exceeds morphine, these endogenous substances are the body’s first line of defense against pain and stress.…

Continue Reading

ThursdayMar 08, 2018 4:00 pm

Building a Portfolio of Industrial Hemp Companies is Key to the Future of Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF)

Global Hemp Group will employ joint ventures, partnerships, and acquisitions to capture cash flow, generate revenues and create value for its shareholders Global Hemp Group will be involved in the cultivation, processing and distribution of industrial hemp to domestic and international markets At the end of 2017, GHG issued its final report on the first year of its joint venture to produce industrial hemp on the Arcadian Peninsula of New Brunswick, Canada Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is focused on the vital role that industrial hemp will play in building a sustainable future. The company…

Continue Reading

ThursdayMar 08, 2018 9:00 am

Acquisitions and Growth Expand in Canadian Cannabis Market

CanadianCannabisWire Editorial Coverage: The first wave of companies to enter the Canadian cannabis industry were grounded in medical marijuana, which was legalized in 2001. As the country prepares for legalized adult recreational-use this summer, new recreational brands are joining the scene, and many companies rooted in medicinal cannabis are taking action to participate in this second wave of the Canadian market. With its strong branding and modern store design, Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF) (CHOOF Profile) is branded to appeal to the Canadian adult consumer ready to experience the cannabis lifestyle. Aurora Cannabis, Inc. (TSX: ACB) (OTCQB: ACBFF)…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977